By western blotting analysis, we found that STRN3 presented lower expression in lung cancer cells (A549, PC9, and H1299) compared with normal bronchial epithelial cells (BEAS‐2B), with the lowest expression in A549 cells (Figure S7C, Supporting Information). Here, STRN3 is linked to lung cancer.